Adherence to COPD treatment increase: is it possible to reduce the cost of treatment?
Annotation. Chronic obstructive pulmonary disease (COPD) makes a significant economic burden for the patients, their families and for the healthcare systems of different countries in general. At the same time the level of adherence to basis therapy is 30–40%. Aim of the study is to determine cost effectiveness of the measures for adherence to COPD treatment increase. 156 patients with COPD (III–IV GOLD) were included into study. The duration of the study was 13 months and it consisted of 6 visits. During each visit the adherence to treatment was measured according to value of inhaler dose counter. The instruction regarding necessity to adhere to basis therapy regimen as well as training of correct inhaler use technique were conducted. The costs for the patient with COPD treatment were calculated for 1 year before the start of the patients’ participation in the study (first year) and during their participation in the study (second year). The average value and standard error of average value were calculated for all the parameters. The comparison of parameters of intergroup differences was made with use of T-test for dependent samples and criterion χ2. It is shown that the adherence to COPD treatment rose from 44.41±1.07% to 75.21±0.78%, i.e. by 30.8% (p<0.001). On the background of adherence increase total cost for the patients treatment due to COPD diminished from 20304.88 ± 976.68 UAH to 9258.13 ± 507.90 UAH, i.e. by 54.4% during the year. Thus, adherence to COPD treatment increase permits to diminish the annual treatment cost for this disease significantly (by 54.4%). Detection of patients' visits frequency to medical institution in order to maintain the level of adherence to treatment which was already achieved has the prospect of further research.
2. Guarascio, A. J. Ray, S. M., Finch, C. K. (2013). The clinical and economic burden of chronic obstructive pulmonary disease in the USA. ClinicoEconomics and Outcomes Research, 5, 235-45. doi: 10.2147/CEOR.S34321.
3. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Global initiative for chronic obstructive lung disease. 2017. Retrieved from https://goldcopd.org/wp-content/uploads/2017/11/GOLD-2018-v6.0-FINAL-revised-20-Nov_WMS.pdf.
4. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Global initiative for chronic obstructive lung disease. 2020. Retrieved from https://goldcopd.org/gold-reports/.
5. Punekar, Y. S., Shukla A., Mullerova H. (2014). COPD management costs according to the frequency of COPD exacerbations in UK primary care. International Journal of Chronic Obstructive Pulmonary Disease, 9, 65–73. doi: 10.2147/COPD.S54417.
This work is licensed under a Creative Commons Attribution 4.0 International License.